Latest news and insights on the pharmaceutical industry | Indian Pharma Post | Page 143

Results For "manufacturing"

1913 News Found

Suven Pharmaceuticals acquires Casper Pharma for Rs 155 crore
News | April 05, 2022

Suven Pharmaceuticals acquires Casper Pharma for Rs 155 crore

Casper Pharma is a Hyderabad based SEZ company engaged in the formulations business. Post-purchase of shares, the target entity would become a wholly-owned subsidiary of SPL


IDMA’s two-day Diamond Jubilee celebrations in Mumbai on April 14-15
News | April 05, 2022

IDMA’s two-day Diamond Jubilee celebrations in Mumbai on April 14-15

The two-day event will showcase achievements and address issues pertaining to the industry


Intas and Axantia sign an exclusive agreement for Ranibizumab biosimilar
Biotech | April 04, 2022

Intas and Axantia sign an exclusive agreement for Ranibizumab biosimilar

Intas has developed a biosimilar of Lucentis, which is currently under Phase III global trial for submission in major countries including EMA & the US


WHO suspends supply of Covaxin under Covax facility
News | April 03, 2022

WHO suspends supply of Covaxin under Covax facility

WHO’s post EUA inspection found deficiencies in Good Manufacturing Practice at the facility


WHO selects Biological E for mRNA tech transfer
News | April 03, 2022

WHO selects Biological E for mRNA tech transfer

Primarily set up to address the Covid-19 emergency, the WHO technology transfer hub has the potential to expand manufacturing capacity for other products as well, including treatments, and target other priorities such as malaria, HIV and cancer


USFDA approves Yescarta as first CAR T-cell therapy for Lymphoma
Biotech | April 03, 2022

USFDA approves Yescarta as first CAR T-cell therapy for Lymphoma

Yescarta is First CAR T-cell therapy to receive NCCN treatment guideline category 1 recommendation --


Lonza Joins International Pharmaceutical Aerosol Consortium
News | April 01, 2022

Lonza Joins International Pharmaceutical Aerosol Consortium

Through this consortium, Lonza will collaborate with other industry leaders to advance the research and development of inhalation technologies


Wipro GE Healthcare launches facility under govt’s PLI scheme
News | April 01, 2022

Wipro GE Healthcare launches facility under govt’s PLI scheme

It is one of the 15 medical device manufacturers approved under the government’s PLI scheme


Biocon Biologics’ partner receives positive EU CHMP opinion for biosimilar human insulin for IV infusion
Biotech | April 01, 2022

Biocon Biologics’ partner receives positive EU CHMP opinion for biosimilar human insulin for IV infusion

Celerity Pharmaceuticals uses Biocon Biologics’ insulin drug substance to develop the product


Arzeda closes US$33 million Series B funding
Digitisation | April 01, 2022

Arzeda closes US$33 million Series B funding

Arzeda harnesses the power of computer-designed enzymes and applies the latest advances in digital biology